Table 2 Age and geographic regions of patients with metastatic colon cancer in the sensitivity analysis (N = 600)
From: Unsupported off-label chemotherapy in metastatic colon cancer
| Â | N (%) | Â | |
|---|---|---|---|
| Â | All subjects 600 | Individuals receiving any of the three unsupported off-label therapies 116 (19%) | p -value |
Age | |||
<50 | 163 (27) | 37 (32) | 0.153 |
50-59 | 233 (39) | 46 (40) | |
60-69 | 130 (22) | 26 (22) | |
>70 | 62 (10) | 7 (6) | |
Unknown | 12 (2) | 0 | |
Region | |||
Midwest | 170 (28) | 29 (25) | 0.597 |
Northeast | 63 (11) | 13 (11) | |
Southeast | 194 (32) | 35 (30) | |
Southwest | 68 (11) | 17 (15) | |
West | 56 (9) | 14 (12) | |
Unknown | 49 (8) | 8 (7) | |